Loading the session
Loading the session
Loading instrument
$14.27
+6.73%Market closedDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:07 IST · A quote does not mean the product is available to trade on your account.
In brief
Questions investors ask
Quotes run fifteen minutes behind.
Closed at $14.21 on 4 Nov 2026: 0.7% below the 52-week high of $14.31 (4 Nov 2026) and 178.6% above the low of $5.10 (6 Nov 2025).
Daily price bars, split-adjusted · as of 4 Nov 2026
1 month: +17.2% (SPY −1.6%, XLV +13.5%). 3 months: +37.0% (SPY −0.4%, XLV +15.5%). 1 year: +185.3% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: LFST, SPY and XLV · as of 4 Nov 2026
The 4 Nov 2026 close of $14.21 was 13.1% above its 50-day average ($12.56) and 50.7% above its 200-day average ($9.43). It has closed above the 200-day for 250 sessions, since 6 Nov 2025. The 50-day average crossed above the 200-day on 9 Dec 2025, 227 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
The 14-session relative strength index closed at 72.3 on 4 Nov 2026, its 1st session at 70 or above. By convention a reading of 70 or above is called overbought and 30 or below oversold.
Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026
13.8M shares were sold short at the 15 Oct 2026 settlement, 3.6% of the 382.2M shares outstanding; covering them would take 4.8 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Price return, split-adjusted
At the 4 Nov 2026 close
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
November 6, 2025
+29.94%February 28, 2024
+30.00%November 9, 2022
−28.91%